Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2012
11/08/2012US20120282182 Nanoparticle clusters formed from individual nanoparticles of two or more types
11/08/2012US20120282181 Methods for detecting a mycobacterium tuberculosis infection
11/08/2012US20120282172 Targeted delivery to human diseases and disorders
11/08/2012US20120282169 Detection and treatment of traumatic brain injury
11/08/2012CA2835015A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012CA2834851A1 Use of radiographic contrast agents for detecting dental caries
11/08/2012CA2832464A1 Novel agonists and antagonists of the urotensinergic system
11/07/2012EP2519152A1 Method and kit for quantifying risk predictor
11/07/2012CN102770460A Novel indocyanine compound, synthesis method thereof, purification method thereof, diagnostic composition using indocyanine compound, and device for measuring in vivo kinetics and device for visualizing circulation using diagnostic composition
11/07/2012CN102770428A Oligothiophene derivate as molecular probes
11/07/2012CN102766602A Animal model for the fast identification of pharmaceutical active compounds in vivo
11/07/2012CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof
11/07/2012CN102766188A Cholesterol derivative, chelate, recombinant high density lipoprotein and application thereof
11/07/2012CN102153871B Preparation method for chiral dendrimers/gold nanoparticles modified by mPEG
11/07/2012CN102078623B Amorphous state iron-based nano magnetic resonance contrast agent material and preparation method thereof
11/07/2012CN102068705B Carbon nanotube/chitosan/magnetic ferrite nanoparticle composite material, and preparation method and application thereof
11/07/2012CN101912624B Active targeting polymer nanoparticle magnetic resonance contrast agent and preparation method thereof
11/07/2012CN101497878B Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use
11/06/2012US8306602 Biopsy cavity marking device
11/06/2012US8303990 Nanophoresis by placing magnetic nanoparticles conjugated with lipids, proteins, hormones, antioxidants, free radical scavengers into a middle region of an ear; magnetically driving particles through a membrane into the fluid of the inner ear; diagnosis or prophylaxis of ear disorders
11/06/2012US8303963 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
11/06/2012US8303936 Optical fluorescent imaging
11/06/2012US8303933 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303932 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/01/2012WO2012149493A2 Hsp90 combination therapy
11/01/2012WO2012149145A2 Ocular detection of amyloid proteins
11/01/2012WO2012148850A2 Radiopaque injectable nucleus hydrogel compositions
11/01/2012WO2012148265A1 Coating for improving the ultrasound visibility
11/01/2012WO2012146364A1 Microparticle and/or nanoparticle vaccine for prophylactic and/or therapeutic application
11/01/2012WO2012121528A3 Magnetic nanocomposite specific for thyroid cancer and use thereof
11/01/2012WO2012118715A3 Non-peptidic quenched fluorescent imaging probes
11/01/2012WO2012108648A3 Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same
11/01/2012WO2012104275A3 Nanoparticles delivery systems, preparation and uses thereof
11/01/2012US20120277623 Methods and Systems of Delivering a Probability of a Medical Condition
11/01/2012US20120277573 Ultrasound-activated nanoparticles as imaging agents and drug delivery vehicles
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276016 Polymer coated magnetic particles
11/01/2012US20120276015 Optical in vivo Imaging Contrast Agents and Methods of Use
11/01/2012US20120276014 Measurement of body fluid volumes
11/01/2012US20120276013 Genetically determined mouse model of resistance to transplantable cancers
11/01/2012US20120276012 Method of Treatment and Screening Method
11/01/2012US20120276011 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
11/01/2012US20120276009 Pharmaceutical composition
11/01/2012US20120276008 Radiopaque injectable nucleus hydrogel compositions
11/01/2012US20120276006 Contrast agents for myocardial perfusion imaging
11/01/2012US20120276005 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
11/01/2012US20120275998 Biodegradable stent comprising an acid scavenging agent
11/01/2012CA2833390A1 Hsp90 combination therapy
10/2012
10/31/2012EP2518014A1 Carbon microparticle and process for production thereof
10/31/2012EP2517732A1 Transnasal labeling composition for tissues of central nervous system, and labeling method and screening method each using the transnasal labeling composition for tissues of central nervous system
10/31/2012EP2517723A1 Compositions and methods of enhancing immune responses
10/31/2012EP2516462A1 Immuno-conjugates and methods for producing them 2
10/31/2012CN102757912A Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging
10/31/2012CN102757911A Salmonella typhimurium X3306lux and applications of salmonella typhimurium X3306lux in living body imaging
10/31/2012CN102757910A Mouse typhus salmonella UF110lux and application of mouse typhus salmonella UF110lux in living body imaging
10/31/2012CN102757789A Rare earth doped gadolinium-potassium fluoride nanometer material for magneto-optical double-module biological marker and preparation method thereof
10/31/2012CN102329438B Magnetic chitosan/doped rare earth compound particles and preparation method thereof
10/31/2012CN102107012B Ultrasound coupling agent
10/31/2012CN102091027B Method for preparing antitumor small interfering RNA carrying magnetic nano probe
10/31/2012CN102008736B Target cyclopeptide modified liposome microbubble and preparation method thereof
10/31/2012CN102000340B Targeted polymer medicament carrier and preparation method and application thereof
10/31/2012CN101732732B Bovine type tuberculin standard substance and preparation method thereof
10/30/2012US8299285 Compounds for imaging and therapy
10/30/2012US8299232 Constructing a DNA chimera for vaccine development against leishmaniasis and tuberculosis
10/30/2012US8299030 Peptide-based compounds
10/30/2012US8298594 Dry animal repellant
10/30/2012US8298521 Treatment for eye disorder
10/30/2012US8298513 Hexatriene-β-carbonyl compound
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/30/2012CA2710642C Crystallization of iodixanol using ultrasound
10/30/2012CA2528460C Magnetic nanoparticles
10/30/2012CA2525184C Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/30/2012CA2512454C Ultrasound contrast agents and process for the preparation thereof
10/30/2012CA2447025C Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject
10/30/2012CA2411374C Dual specificity antibodies and methods of making and using
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/26/2012WO2012145733A1 Para-hydrogen polarizer
10/26/2012WO2012144716A1 Nanoparticle-based vaccine delivery system having double functions of imaging and delivery
10/26/2012WO2012143508A1 Cross-linked poly-e-lysine particles
10/26/2012WO2012143355A1 Preparation of high-purity gadobutrol
10/26/2012WO2012142702A1 Targeted contrast agents and uses thereof
10/26/2012WO2012142670A1 Nuclear magnetic resonance agent
10/26/2012WO2012110835A3 Prussian blue based nanoparticle as multimodal imaging contrast material
10/26/2012WO2012105794A3 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same
10/26/2012WO2012104277A3 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
10/26/2012WO2012094620A3 Hydrophobic molecule-induced branched polymer aggregates and their use
10/26/2012WO2012031250A8 Compositions for labeling nerves and methods of use
10/26/2012WO2012018948A3 Combination therapy for the treatment of prostate carcinoma
10/26/2012CA2833695A1 Cross-linked poly-e-lysine particles
10/26/2012CA2833659A1 Preparation of high-purity gadobutrol
10/26/2012CA2833587A1 Targeted contrast agents and uses thereof
10/25/2012US20120272347 Chitosan-alginate scaffold cell culture system and related methods
10/25/2012US20120272346 Identification of rnai targets and use of rnai for rational therapy of chemotherapy-resistant leukemia and other cancers
10/25/2012US20120272343 Stromal interacting molecule knockout mouse and uses thereof
10/25/2012US20120270788 Method of Administering Porcine B-Domainless fVIII
10/25/2012US20120270757 Site-specific labeling of affinity tags in fusion proteins
10/25/2012US20120269895 Dendritic pic micelles with bioactive proteins
10/25/2012US20120269738 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation
10/25/2012US20120269736 Micellar compositions for use in biological applications
10/25/2012US20120269735 Contrast Agents and Methods for Preparing Contrast Agents
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 354